April 25, 2023
Multiple myeloma is a silent invader
Multiple myeloma is cancer of the immune system. Oncologist Sascha Tuchman, MD, MHS, shares what you need to know about the condition and treatment.
April 25, 2023
Multiple myeloma is cancer of the immune system. Oncologist Sascha Tuchman, MD, MHS, shares what you need to know about the condition and treatment.
April 25, 2023
Amy Gladfelter, PhD, was elected to the American Academy of Arts & Sciences. She is the eighth current UNC Lineberger member to earn this honor.
April 20, 2023
Justin Yopp, PhD, was elected as a fellow of the APOS, a distinction that recognizes and honors people who make outstanding contributions to the science and practice of psychosocial oncology.
April 19, 2023
Testicular cancer is the most common cancer among young adult males. While testicular cancer is very treatable, “there are a lot of survivorship implications,” says Hung-Jui “Ray” Tan, MD.
April 11, 2023
The new Parenting with Cancer Clinic will help cancer patients talk to their children openly and honestly about their cancer, and to help with legal issues that can accompany cancer, such as end-of-life decisions, wills, trusts and custody agreements.
April 11, 2023
The AACR has elected Charles Perou, PhD, as a fellow to the AACR Academy. Members of this year’s class will be formally recognized at the AACR’s annual meeting.
April 10, 2023
UNC Lineberger faculty and trainees will be presenting their research findings and sharing their insights at education sessions during the American Association for Cancer Research’s annual meeting April 14-19.
April 10, 2023
Albert Brunson didn’t tell anyone but his wife when he was diagnosed with prostate cancer. But a neighbor's death from metastatic prostate cancer changed his mind about sharing his story.
April 10, 2023
Physician-scientist and cancer survivor Chad Pecot, MD, is focused on RNA discoveries in the lab and the clinic.
March 27, 2023
The NCI has awarded has awarded Shelley Earp, MD, and Yuliya Pylayeva-Gupta, PhD, a research project grant to investigate approaches to overcome barriers to pancreatic cancer immunotherapies.